Paul Hastings LLP, a leading global law firm, announced today that the firm represented UBS AG, Stamford Branch, as administrative agent, and UBS Securities LLC, Wells Fargo Securities, LLC and GE Capital Markets, Inc., as joint lead arrangers, in connection with the amendment and restatement of the $375 million dollar equivalent first lien credit facilities and the entry into a new $135 million second lien term loan credit facility of Pharmaceutical Research Associates, Inc. for the purposes of, among other things, refinancing existing indebtedness and the payment of a shareholder dividend.
Leveraged finance partners Mario Ippolito and Michael Michetti led the Paul Hastings team, which also included associates Christopher Ross, Joseph Fastiggi, Heidi Spalholz, Valerie Silverman and Donald Boyajian.
